CCI
20
-11
AMG
49
14
K
48
3
VLO
26
3
DVA
65
3
CINF
35
11
PRU
45
6
ACN
50
-6
VIX
25
-18
OXY
34
-8
PHM
46
2
M
46
6
WY
36
5
LMT
39
10
TAP
54
-3
AVGO
76
2
SYY
41
-2
TRV
37
3
ISRG
66
2
PFG
30
3
CCI
20
-11
AMG
49
14
K
48
3
VLO
26
3
DVA
65
3
CINF
35
11
PRU
45
6
ACN
50
-6
VIX
25
-18
OXY
34
-8
PHM
46
2
M
46
6
WY
36
5
LMT
39
10
TAP
54
-3
AVGO
76
2
SYY
41
-2
TRV
37
3
ISRG
66
2
PFG
30
3
Financhill
Back

Akero Therapeutics 10K Form

Sell
25

AKRO
Akero Therapeutics

Last Price:
$28.56
Seasonality Move:
-9.11%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive AKRO News And Ratings

See the #1 stock for the next 7 days that we like better than AKRO

AKRO Financial Statistics

Sales & Book Value

Annual Sales: --
Cash Flow: $-70.4M
Price / Cash Flow: 0
Annual Sales: $10.61
Price / Book: 2.68

Profitability

EPS (TTM): -3.78000
Net Income (TTM): $-237.2M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

Akero Therapeutics Earnings Forecast

Key Akero Therapeutics Financial Ratios

  • The Interest Expense is -2.04% of Operating Income.
  • Per Share Earnings over the last 6 years have been positive in 3 years.

Akero Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: AKRO
CUSIP: 00973Y
Website: akerotx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

AKRO Technical Analysis vs Fundamental Analysis

Sell
25
Akero Therapeutics (AKRO) is a Sell

Is Akero Therapeutics a Buy or a Sell?